Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
about
Reporting bias in medical research - a narrative reviewImplantable defibrillators versus medical therapy for cardiac channelopathiesImplantable defibrillators versus medical therapy for cardiac channelopathiesRamelteon for insomniaSystemic administration of local anesthetic agents to relieve neuropathic painLimitations of medical research and evidence at the patient-clinician encounter scaleStatistical Methods for Cardiovascular ResearchersMutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasTreating patients with ventricular ectopic beatsState-dependent trapping of flecainide in the cardiac sodium channelBiomarkers and surrogate endpointsCellular and Molecular Mechanisms of Arrhythmia by Oxidative StressAtrial fibrillation in heart failure: what should we do?Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safetyMechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulenceMechanisms of altered Ca²⁺ handling in heart failurePharmacologic management of arrhythmiasNew therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)Practical clinical trials in psychopharmacology: a systematic reviewOptimal antiarrhythmic drug therapy for electrical stormChannel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular CardiomyocytesCardiac dynamics: Alternans and arrhythmogenesis2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesUnraveling the genetics and mechanisms of cardiac arrhythmia.MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotectionElectrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodaroneStructure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activatorsBayesians in clinical trials: asleep at the switch.Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias.Annals of Medicine and Surgery - A modern Journal for Modern Trainees.A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythmsMonitoring clinical trials--interim data should be publicly availableImplementation of a data and safety monitoring program in a general clinical research center.Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.Azimilide dihydrochloride: a new class III anti-arrhythmic agent.Management of the older person with atrial fibrillation.Toxicologic myocardial sensitization.Palpitations and arrhythmias. Separating the benign from the dangerous.
P2860
Q21203744-B01E6C24-BC38-4E6B-ACEF-E9F797DEF013Q24186596-710C7382-3D58-4F18-80FA-BD6FD2DB1593Q24194254-BA240959-1FAE-445E-A81C-943FD762A5ACQ24198232-033DA7E7-9E6F-4FAA-87CD-5B9476DC8547Q24245505-4F041989-0295-4105-9A63-40C97862DA93Q24282606-1D197898-F5E3-4C21-9C8E-44DF7755589EQ24289000-BECC005E-CB15-47E2-93D6-00DC5982246EQ24298971-2ABEE8B7-6CCC-4CE1-B7AF-F5D50B5554C0Q24675999-0126C73C-BC17-4BAA-989C-131DA2AD2C88Q24677114-308572A3-9A4D-4A73-8B16-29187296F82DQ24678760-92821228-F616-4FC2-98CD-AE4C5014C880Q26765076-79DFE194-1FF1-4902-B455-7000D6C5DB27Q26784426-D26D7468-F8E6-4D9C-8FAC-A49C73ABFCD9Q26852003-3EC304FD-6F62-41B8-BD05-D0B36788B2E6Q27009543-FC0C5C5D-986A-4E55-A61C-55795364AFD4Q27012758-9E4B4532-8504-44FB-BFDA-86359BA2ECA0Q27014008-B7D928ED-70C4-44AE-B870-53790EB558D6Q27016402-E8163169-5360-4BA0-B656-F65FAFF075A0Q27021467-AC920C4B-29FC-4567-8BB8-2D365E957A22Q27027096-28756424-3B87-4143-B3F7-6582DB258AB7Q27303698-0E9B9CB1-A919-4356-B53F-710712243F41Q28075339-203D1CB7-ECF1-47B2-9C96-3AA8E5DA864EQ28087002-412EF91A-E3F5-42AB-BA29-539E6BA171E6Q28182631-C42C01FF-2653-472E-A06F-90054E9E804CQ28216187-3BD6412B-C510-4B14-94E7-F3CBBC572B3EQ28251007-4A1D74D1-3A91-4542-AC15-F15E2BF37653Q28367852-E2CDBDBD-1F3C-4310-9B28-5EA12D752EABQ28542822-93C6E3FD-D0C3-42D4-A376-41CD6F1F0450Q30362357-A5B90F64-2B78-40DD-8949-A99C2DDAA14AQ30486315-690725F8-5D82-4D2C-A02A-261B1F88EE67Q30488204-488968A1-B1AE-48C6-90C8-3B2ED4CB8086Q30513464-726626B9-2DB8-4BBD-AEC5-7C581218CB5DQ30659185-C7CE371F-F361-4D37-BFF6-86D47F71697BQ30666458-1768570A-9E34-4691-8577-50E626081F4AQ30973910-61AF5D23-A789-4F6A-B5D0-CC26C0149009Q31122463-440CC5C2-211E-4852-A9C0-2D4D8B563D0BQ31522245-F6904438-9192-445C-88FF-94932563A656Q33144789-805312E0-84CB-459A-8D30-77BF17EDABC8Q33148458-00F78DF2-2BE8-4D50-B85C-4C32DB74FA2BQ33154790-15A3E606-6513-4BB4-A088-D495E04E82CC
P2860
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
description
1989 nî lūn-bûn
@nan
1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Preliminary report: effect of ...... n after myocardial infarction.
@ast
Preliminary report: effect of ...... n after myocardial infarction.
@en
Preliminary report: effect of ...... n after myocardial infarction.
@nl
type
label
Preliminary report: effect of ...... n after myocardial infarction.
@ast
Preliminary report: effect of ...... n after myocardial infarction.
@en
Preliminary report: effect of ...... n after myocardial infarction.
@nl
prefLabel
Preliminary report: effect of ...... n after myocardial infarction.
@ast
Preliminary report: effect of ...... n after myocardial infarction.
@en
Preliminary report: effect of ...... n after myocardial infarction.
@nl
P1476
Preliminary report: effect of ...... n after myocardial infarction.
@en
P2093
Cardiac Arrhythmia Suppression Trial (CAST) Investigators
P304
P356
10.1056/NEJM198908103210629
P407
P577
1989-08-01T00:00:00Z